---
figid: PMC8042594__jitc-2020-002285f01
figlink: pmc/articles/PMC8042594/figure/F1/
number: F1
caption: (A) Monocytic and macrophage contribution to SARS-CoV-2 hyperinflammation.
  SARS-CoV-2 directly infects pulmonary pneumocytes, causing cell death and the release
  of danger-associated molecular patterns, activating macrophages. Viral spike protein
  also triggers release of inflammatory cytokines, including interleukin (IL)-1β,
  IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage inflammatory
  protine (MIP)-1 by alveolar-resident macrophages, promoting monocytic infiltration.
  Additionally, internalization of ACE2 on viral entry leads to increased angiotensin
  II, facilitating reactive oxygen species production, tissue damage, and an NF-κB-driven
  inflammatory gene expression program that includes production of chemokines, cytokines,
  and IL-6. (B) Contribution of IL-6 signaling to COVID-19 inflammatory cascade. Trimeric
  complex formation with IL-6, IL-6R and gp130 leads to dimerization and autophosphorylation
  of JAK1. Phosphorylated JAK1 triggers STAT3 phosphorylation and translocation to
  the nucleus, initiating acute-phase protein production, including chemokines, cytokines
  and IL-6. Phospho-JAK1 may also contribute to acute-phase transcription through
  an extracellular signal-regulated kinase (ERK)-dependent pathway that relies on
  SHP2 and Ras. Notably, IL-6 also induces expression of SOCS1 and SOC3, which negatively
  regulate JAK/STAT signaling. The classical signaling pathway is largely restricted
  to the lymphocyte compartment, where it contributes to adaptive immunity, whereas
  trans signaling may occur in any tissue type and is generally pro-inflammatory.
  Interventions that may alleviate inflammatory IL-6 signaling (ie, tocilizumab or
  tyrosine kinase inhibitors) are shown.
pmcid: PMC8042594
papertitle: 'IL-6 modulation for COVID-19: the right patients at the right time?.'
reftext: Paolo Antonio Ascierto, et al. J Immunother Cancer. 2021;9(4):e002285.
pmc_ranked_result_index: '56810'
pathway_score: 0.5605797
filename: jitc-2020-002285f01.jpg
figtitle: ' Monocytic and macrophage contribution to SARS-CoV-2 hyperinflammation'
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8042594__jitc-2020-002285f01.html
  '@type': Dataset
  description: (A) Monocytic and macrophage contribution to SARS-CoV-2 hyperinflammation.
    SARS-CoV-2 directly infects pulmonary pneumocytes, causing cell death and the
    release of danger-associated molecular patterns, activating macrophages. Viral
    spike protein also triggers release of inflammatory cytokines, including interleukin
    (IL)-1β, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage
    inflammatory protine (MIP)-1 by alveolar-resident macrophages, promoting monocytic
    infiltration. Additionally, internalization of ACE2 on viral entry leads to increased
    angiotensin II, facilitating reactive oxygen species production, tissue damage,
    and an NF-κB-driven inflammatory gene expression program that includes production
    of chemokines, cytokines, and IL-6. (B) Contribution of IL-6 signaling to COVID-19
    inflammatory cascade. Trimeric complex formation with IL-6, IL-6R and gp130 leads
    to dimerization and autophosphorylation of JAK1. Phosphorylated JAK1 triggers
    STAT3 phosphorylation and translocation to the nucleus, initiating acute-phase
    protein production, including chemokines, cytokines and IL-6. Phospho-JAK1 may
    also contribute to acute-phase transcription through an extracellular signal-regulated
    kinase (ERK)-dependent pathway that relies on SHP2 and Ras. Notably, IL-6 also
    induces expression of SOCS1 and SOC3, which negatively regulate JAK/STAT signaling.
    The classical signaling pathway is largely restricted to the lymphocyte compartment,
    where it contributes to adaptive immunity, whereas trans signaling may occur in
    any tissue type and is generally pro-inflammatory. Interventions that may alleviate
    inflammatory IL-6 signaling (ie, tocilizumab or tyrosine kinase inhibitors) are
    shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - IL6
  - CSF2
  - ACE2
  - IL6R
  - HRAS
  - KRAS
  - NRAS
  - JAK1
  - JAK3
  - PTPN11
  - SOCS3
  - ARAF
  - BRAF
  - RAF1
  - STAT3
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - CXCL1
  - CXCL2
  - CXCL10
  - CXCL9
  - CXCL6
  - CXCL11
  - CXCL5
  - CXCL14
  - CXCL3
  - CXCL8
  - PF4
  - PPBP
  - CXCL12
  - CXCL13
  - GDP
  - SARS-CoV-2
genes:
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: GM-CSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: SHP2
  symbol: SHP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: (socs3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: GDP
  source: MESH
  identifier: D006153
diseases:
- word: SARS-CoV-2
  source: MESH
  identifier: C000657245
figid_alias: PMC8042594__F1
redirect_from: /figures/PMC8042594__F1
figtype: Figure
---
